Alzheimer’s treatment shows promise
(SNN) A recent clinical trial is showing promise for early-stage Alzheimer’s patients. Years ago Roskamp Institute Executive Director Dr. Michael Mullan and other researchers were interested in how a drug called Nilvadipine could affect Alzheimer’s. “We first started looking at this drug because it’s anti-hypertensive, and it has the ability to open up blood vessels in the brain,” Dr. Mullan…
